Results 201 to 210 of about 166,832 (321)

Beriplex P/N reverses severe warfarin‐induced overanticoagulation immediately and completely in patients presenting with major bleeding [PDF]

, 2001
Gillian Evans, Roger Luddington, Trevor Baglin   +2 more
openalex   +1 more source

High Rates of Defect Closure After Resection of Large Nonpedunculated Colorectal Lesions Using a Through‐The‐Scope Clip With Anchor Prongs

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Prophylactic complete closure of mucosal defects after resection of gastrointestinal lesions is key to reducing delayed bleeding, but complete closure for large defects can be challenging with conventional through‐the‐scope clips (TTSC).
Daniel von Renteln, Douglas K. Rex, Heiko Pohl, Nikhil A. Kumta, Shannon Chan, Marvin Ryou, Zaheer Nabi, Ping Hong Zhou, Haruhiro Inoue, Joyce A. Peetermans, Matthew J. Rousseau, Jeffrey D. Mosko   +11 more
wiley   +1 more source

Warfarin and bevacizumab suppress tumor progression in pancreatic ductal adenocarcinoma by targeting EGFR-PI3K-Akt signaling: inhibition of proliferation/migration and apoptosis induction. [PDF]

Transl Cancer Res
Chen J, Ju J, Wang J, Yang L.
europepmc   +1 more source

Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants [PDF]

, 2017
Nathan P. Clark, Kim Hoang, Thomas Delate, John R. Horn, Daniel M. Witt   +4 more
openalex   +1 more source

The incidence of serious complications after selective laser trabeculoplasty

Acta Ophthalmologica, Volume 104, Issue 1, Page 106-113, February 2026.
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen, Joni A. Turunen, Mika Harju   +2 more
wiley   +1 more source

The Impact of Direct Oral Anticoagulants vs. Warfarin on Stroke Prevention in Elderly Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Majid S, Rangachari B, Okata D, Kyaw O, Mahmood H, Khan S, Abid M.   +6 more
europepmc   +1 more source

To investigate the rates and contributing factors to adverse drug events for patients treated with non-vitamin K antagonist oral anticoagulants versus warfarin, a vitamin K antagonist

, 2020
Kerry Louise Watts
openalex   +1 more source

Are Sequential CT Scans Necessary in Patients on Warfarin with a Minor Head Injury and Initial Normal CT of the Brain?

, 2020
Saptarshi Biswas, Marcus Wilson, Ronald Peirish, Daniel Martin Kaeli Freeborough, George McKenny Lauren Sciullo, Hina Dalal Shruti Varma, Raahil Malhotra, Joni Krydick, Diane V Thompson   +8 more
openalex   +1 more source

Predicting the Quality of Warfarin Therapy: Reframing the Question [PDF]

, 2019
Geoffrey D. Barnes
openalex   +1 more source

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Efavirenz's effects on cytochrome P450 2C9 (CYP2C9) activity have not been formally characterized in vivo. We conducted the first clinical drug–drug interaction (DDI) study to test the effect of chronic efavirenz dosing on CYP2C9 activity, using tolbutamide as a selective probe.
Jason D. Kim, Ingrid F. Metzger, Jessica Bo Li Lu, Todd C. Skaar, Zeruesenay Desta   +4 more
wiley   +1 more source